The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Workforce
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Skin Disease in Rheumatology Patients Should Prompt Collaboration with Dermatologists

Skin Disease in Rheumatology Patients Should Prompt Collaboration with Dermatologists

March 1, 2015 • By Vanessa Caceres

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Topical Steroids

Rheumatologists are sometimes uncomfortable treating skin disease in their patients—but there’s inevitably a clinical situation in which a patient presents with a rash, and you think that a short course of topical steroids might help. You may be certain the rash is related to the patient’s condition or medications used for that condition, be it psoriasis, psoriatic arthritis, cutaneous lupus or dermatomyositis.

You Might Also Like
  • 7 Tips That Dermatologists Want Rheumatologists to Know
  • What Rheumatologists Wish Their Colleagues Knew: Managing Skin Disease & Comorbidities
  • 2013 ACR/ARHP Annual Meeting: Inflammatory Eye Disease Management Can Benefit from Collaboration between Rheumatologists and Ophthalmologists
Explore This Issue
March 2015
Also By This Author
  • 7 Things Ophthalmologists Want Rheumatologists to Know

For example, when treating psoriatic arthritis, “Although systemic treatments can work in the skin, it’s not uncommon to have residual skin disease,” says dermatologist and rheumatologist Joseph F. Merola, MD, Brigham and Women’s Hospital, Harvard Medical School, Boston. “It’s great if the rheumatologist has some level of comfort with the appropriate use of topical steroids,” says Dr. Merola, who has instructed on the topic.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Perhaps the dermatologists in your area are extremely busy, or the patient does not want to be shuttled to different specialists. Or perhaps you want to offer the patient some relief while they wait to be seen by a local dermatologist.

Here’s some guidance on what to prescribe, possible side effects and when you should leave the diagnosis and treatment to a dermatologist.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

What to Use

Topical corticosteroids range in potency from 1 to 7. Over-the-counter topicals have a potency of 7, at the lowest possible range. The highest potency topicals have a 1 ranking.

Rheumatologists should get to know one mild, one moderate and one potent topical treatment, Dr. Merola advises. One online resource that may help is the Topical Steroids Potency Chart, published by the National Psoriasis Foundation.

There are three specific steroids that dermatologist Ellen Frankel, MD, Rejuviderm MediSpa, Cranston, R.I., feels comfortable with nondermatologists prescribing: desonide (class 6), triamcinolone (class 4) or a short burst of clobetasol, which is a more potent therapy (class 1). A report in the January 2015 issue of Dermatologic Clinics focusing on topical therapies for psoriasis reported that clobetasol spray allows patients to apply steroids in areas that may be difficult to reach and may be more potent than the ointment formulation.1 Additionally, clobetasol propionate and betamethasone valerate in foam formulations dry rapidly, with little residue left on the skin.1

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Topical steroids range in formulation from gels to liquids to ointments, the latter being the strongest, says Kate Ross, MD, LA Plastic Surgery and Dermatology, Bradenton, Fla. Each formulation has its advantages, depending on where it is used on the body, greasiness and ease of application, according to a paper on topical corticosteroids coauthored by Dr. Ross.2

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Practice Management Tagged With: dermatologist, rheumatologist, skin disease, Steroid, TreatmentIssue: March 2015

You Might Also Like:
  • 7 Tips That Dermatologists Want Rheumatologists to Know
  • What Rheumatologists Wish Their Colleagues Knew: Managing Skin Disease & Comorbidities
  • 2013 ACR/ARHP Annual Meeting: Inflammatory Eye Disease Management Can Benefit from Collaboration between Rheumatologists and Ophthalmologists
  • Anti-TNF-Associated Skin Lesions Common in Inflammatory Bowel Disease

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.